Vistagen Therapeutics (VTGN) Operating Income (2010 - 2026)
Vistagen Therapeutics' Operating Income was -$10.94 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$20.05 million a year earlier.
Vistagen Therapeutics (VTGN) Operating Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vistagen Therapeutics' Operating Income was -$60.55 million through Sep 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at -$72.13 million.
- In earlier fiscal years, Operating Income was -$55.97 million in FY2025, -$33.02 million in FY2024, -$59.27 million in FY2023 and -$47.78 million in FY2022.
- The fiscal Q2 2027 figure marks the highest quarterly Operating Income since fiscal Q3 2024.
- Per Business Quant data, VTGN's Operating Income in the three fiscal quarters before Q2 2027 was -$13.35 million (Q1 2027), -$16.72 million (Q4 2026) and -$19.55 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -1.93 Mn |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 8.41 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 6.18 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 6.27 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 5.56 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | -10.94 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -10.94 Mn |
| Jun 30, 2026 | -13.35 Mn |
| Mar 31, 2026 | -16.72 Mn |
| Dec 31, 2025 | -19.55 Mn |
| Sep 30, 2025 | -20.05 Mn |
| Jun 30, 2025 | -15.80 Mn |
| Mar 31, 2025 | -14.50 Mn |
| Dec 31, 2024 | -15.12 Mn |
| Sep 30, 2024 | -14.23 Mn |
| Jun 30, 2024 | -12.13 Mn |
| Mar 31, 2024 | -11.36 Mn |
| Dec 31, 2023 | -7.88 Mn |
| Sep 30, 2023 | -6.78 Mn |
| Jun 30, 2023 | -7.00 Mn |
| Mar 31, 2023 | -12.24 Mn |
| Dec 31, 2022 | -9.77 Mn |
| Sep 30, 2022 | -17.49 Mn |
| Jun 30, 2022 | -19.77 Mn |
| Mar 31, 2022 | -16.69 Mn |
| Dec 31, 2021 | -10.54 Mn |
Vistagen Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();